시장보고서

상품코드

1552571

전부 포도막염 치료 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 치료별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Anterior Uveitis Treatment Market Size, Share & Trends Analysis Report By Type (Infectious Uveitis), By Therapy (Biologics), By Distribution Channel (Hospital, Retail, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

발행일: 2024년 08월 | 리서치사:

Grand View Research | 페이지 정보: 영문 120 Pages | 배송안내 : 2-10일 (영업일 기준)

샘플 요청 목록에 추가

※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

전부 포도막염 치료(Anterior Uveitis Treatment) 시장 성장 및 동향 :

Grand View Research, Inc.의 최신 보고서에 따르면 전 세계 포도막염 치료 시장 규모는 2024년부터 2030년까지 12.6%의 CAGR을 기록했으며 2030년까지 9억 6,750만 달러에 달할 전망입니다.

이 질병의 유병률 증가는 시장 성장을 가속할 것으로 예상됩니다. 이 질병은 일반 포도막염, 후부 포도막염, 중간부 포도막염과 비교할 때 더 흔합니다.

Retina Today의 2017년 기사에 따르면, 이 질환은 포도막염 사례의 약 30%에서 90%를 차지합니다. 또한 환자의 약 1%에서 4%가 25%의 시력 저하를 경험한다고 말합니다. 이 질병에는 다양한 효과적인 치료법이 있으며 관리가 쉽지만 재발하는 경향이 있습니다. 이 질병은 청소년층에서 중년층까지 널리 나타납니다. 또한 노인에게도 자주 볼 수 있습니다. 안허혈과 헤르페스성 포도막염이 노년 인구에 많은 원인입니다. 대부분의 경우는 건강한 사람에게 발생하지만, 감염증, 소화기 질환, 류마티스성 질환, 폐·피부 질환에 수반되는 경우도 있습니다. 이 질환은 후부 포도막염에 비해 시력을 위협하는 경우가 적지만, 경우에 따라 녹내장, 백내장, 낭종과 같은 황반 부종을 일으킬 수 있습니다.

전부 포도막염 치료 시장 보고서· 하이라이트

2023년 전부 포도막염 치료 시장은 눈의 염증을 최소화하는 코르티코 스테로이드가 그 유익한 특성에 의해 지배적이었습니다. 코르티코 스테로이드는 주요 치료 수단입니다.
항-TNF 제형은 항-TNF 제제를 이용한 생물학적 제제로 치료의 기회를 확대함으로써 예측 기간 동안 유리한 성장률을 나타낼 것으로 예상됩니다.
면역억제제는 만성 전부 포도막염 치료에 대한 채택 확대로 2023년에 큰 시장 점유율을 차지했습니다.
2023년 시장은 폭넓은 치료 옵션이 있는 병원 약국이 우위를 차지한다
온라인 약국은 편의성, 간편성 및 할인 제품의 가용성으로 인해 예측 기간 동안 높은 CAGR을 나타낼 것으로 기대됩니다.
북미는 2023년에 가장 큰 판매 점유율을 차지했으며, 이는 이 지역의 높은 유병률과 건강 관리 지출로 인한 것입니다.
아시아 태평양은 이 지역의 신흥 국가에서 감염증 증가와 가처분 소득 증가로 예측 기간 동안 유리한 성장을 보일 것으로 예상됩니다.

전부 포도막염 치료 시장 점유율, 지역별(2023년, 2030년)
북미
- 미국
- 캐나다
- 멕시코
유럽
- 영국
- 독일
- 프랑스
- 이탈리아
- 스페인
- 덴마크
- 스웨덴
- 노르웨이
아시아 태평양
- 일본
- 중국
- 인도
- 호주
- 한국
- 태국
남미
- 브라질
- 아르헨티나
중동 및 아프리카
- 남아프리카공화국
- 사우디아라비아
- 아랍에미리트(UAE)
- 쿠웨이트

제8장 경쟁 구도

주요 시장 진출기업의 최근 동향 및 영향 분석
기업 분류
기업 히트맵 분석
기업 프로파일
- Novartis AG
- Santen Pharmaceutical Co., Ltd
- AbbVie Inc.
- Kiora Pharmaceuticals, Inc.
- Clearside Biomedical
- Aldeyra Therapeutics, Inc.
- UCB SA
- Agilent Technologies, Inc.(Lux Biosciences, Inc.)
- Tarsier Pharma Ltd.

LYJ

Anterior Uveitis Treatment Market Growth & Trends:

The global anterior uveitis treatment market size is expected to reach USD 967.5 million by 2030, registering a CAGR of 12.6% from 2024 to 2030, according to a new report by Grand View Research, Inc. Rising prevalence of the disease is anticipated to aid market growth. This disease is more common when compared to panuveitis, posterior, and intermediate uveitis.

According to a 2017 article by Retina Today, this condition accounted for around 30% to 90% of the cases of uveitis. It also stated around 1% to 4% of patients experience 25% loss of visual acuity. There are different effective treatments for this disease and can be easily managed; however, it tends to recur. This disease is prevalent among both young and middle-aged group. It is also common among the geriatric population. Ocular ischemia and herpetic uveitis are the two most common causes of this disease among the geriatric population. Most of the cases occur in healthy people, however, some are associated with infectious diseases, gastrointestinal disorders, rheumatologic diseases, and lung & skin diseases. This disease is less sight-threatening as compared to posterior uveitis, however, in some cases might lead to glaucoma, cataract, and cystoid macular edema.

Anterior Uveitis Treatment Market Report Highlights:

Corticosteroids dominated the anterior uveitis treatment market in 2023 owing to its beneficial characteristic of minimizing inflammation in the eye. It is the primary treatment modality.
Anti-TNF agents are expected to exhibit lucrative growth rate over the forecast period due to growing opportunity in treatment methods with biologic therapy using Anti-TNF drugs.
Immunosuppressants held a significant market share in 2023 owing to their growing adoption for treatment of chronic anterior uveitis.
Hospital pharmacies dominated the market in 2023 due to the wide treatment options available there.
Online pharmacies are expected to witness significant CAGR over the forecast period due to convenience, ease, and availability of discounted products.
North America held the largest revenue share in 2023 owing to high prevalence as well as healthcare expenditure in this region.
Asia Pacific is anticipated to exhibit lucrative growth during the forecast period due to the rising number of infectious diseases in developing countries of the region and growing disposable income.

Chapter 1. Methodology and Scope

1.1. Market Segmentation and Scope
1.2. Market Definitions
1.3. Research Methodology
- 1.3.1. Information Procurement
- 1.3.2. Information or Data Analysis
- 1.3.3. Market Formulation & Data Visualization
- 1.3.4. Data Validation & Publishing
1.4. Research Scope and Assumptions
- 1.4.1. List of Data Sources

Chapter 2. Executive Summary

2.1. Market Outlook
2.2. Segment Outlook
2.3. Competitive Insights

Chapter 3. Anterior Uveitis Treatment Market Variables, Trends, & Scope

3.1. Market Introduction/Lineage Outlook
3.2. Market Size and Growth Prospects (USD Million)
3.3. Market Dynamics
- 3.3.1. Market Drivers Analysis
- 3.3.2. Market Restraints Analysis
3.4. Anterior Uveitis Treatment Market Analysis Tools
- 3.4.1. Porter's Analysis
  - 3.4.1.1. Bargaining power of the suppliers
  - 3.4.1.2. Bargaining power of the buyers
  - 3.4.1.3. Threats of substitution
  - 3.4.1.4. Threats from new entrants
  - 3.4.1.5. Competitive rivalry
- 3.4.2. PESTEL Analysis
  - 3.4.2.1. Political landscape
  - 3.4.2.2. Economic and Social landscape
  - 3.4.2.3. Technological landscape
  - 3.4.2.4. Environmental landscape
  - 3.4.2.5. Legal landscape

Chapter 4. Anterior Uveitis Treatment Market: Type Estimates & Trend Analysis

4.1. Segment Dashboard
4.2. Anterior Uveitis Treatment Market: Type Movement Analysis, 2023 & 2030 (USD Million)
4.3. Infectious Uveitis
- 4.3.1. Infectious Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
4.4. Non-Infectious Uveitis
- 4.4.1. Non-Infectious Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.1.1. Anterior Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.1.2. Pan-Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.1.3. Posterior Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
  - 4.4.1.4. Intermediate Uveitis Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 5. Anterior Uveitis Treatment Market: Therapy Estimates & Trend Analysis

5.1. Segment Dashboard
5.2. Anterior Uveitis Treatment Market: Therapy Movement Analysis, 2023 & 2030 (USD Million)
5.3. Corticosteroids
- 5.3.1. Corticosteroids Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.4. Immunosuppressive Therapies
- 5.4.1. Immunosuppressive Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.5. Biologics
- 5.5.1. Biologics Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.6. Others
- 5.6.1. Others Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
5.7. Pipeline Therapies
- 5.7.1. Pipeline Therapies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 6. Anterior Uveitis Treatment Market: Distribution Channel Estimates & Trend Analysis

6.1. Segment Dashboard
6.2. Anterior Uveitis Treatment Market: Distribution Channel Movement Analysis, 2023 & 2030 (USD Million)
6.3. Hospital Pharmacies
- 6.3.1. Hospital Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.4. Retail Pharmacies
- 6.4.1. Retail Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)
6.5. Online Pharmacies
- 6.5.1. Online Pharmacies Market Revenue Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 7. Anterior Uveitis Treatment Market: Regional Estimates & Trend Analysis

7.1. Anterior Uveitis Treatment Market Share, By Region, 2023 & 2030 (USD Million)
7.2. North America
- 7.2.1. North America Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.2. U.S.
  - 7.2.2.1. U.S. Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.3. Canada
  - 7.2.3.1. Canada Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.2.4. Mexico
  - 7.2.4.1. Mexico Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.3. Europe
- 7.3.1. Europe Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.2. UK
  - 7.3.2.1. U K Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.3. Germany
  - 7.3.3.1. Germany Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.4. France
  - 7.3.4.1. France Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.5. Italy
  - 7.3.5.1. Italy Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.6. Spain
  - 7.3.6.1. Spain Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.7. Denmark
  - 7.3.7.1. Denmark Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.8. Sweden
  - 7.3.8.1. Sweden Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.3.9. Norway
  - 7.3.9.1. Norway Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.4. Asia Pacific
- 7.4.1. Asia Pacific Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.2. Japan
  - 7.4.2.1. Japan Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.3. China
  - 7.4.3.1. China Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.4. India
  - 7.4.4.1. India Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.5. Australia
  - 7.4.5.1. Australia Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.6. South Korea
  - 7.4.6.1. South Korea Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.4.7. Thailand
  - 7.4.7.1. Thailand Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.5. Latin America
- 7.5.1. Latin America Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.2. Brazil
  - 7.5.2.1. Brazil Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.5.3. Argentina
  - 7.5.3.1. Argentina Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
7.6. Middle East and Africa
- 7.6.1. Middle East and Africa Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.2. South Africa
  - 7.6.2.1. South Africa Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.3. Saudi Arabia
  - 7.6.3.1. Saudi Arabia Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.4. UAE
  - 7.6.4.1. UAE Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)
- 7.6.5. Kuwait
  - 7.6.5.1. Kuwait Anterior Uveitis Treatment Market Estimates and Forecasts, 2018 - 2030 (USD Million)

Chapter 8. Competitive Landscape

8.1. Recent Developments & Impact Analysis by Key Market Participants
8.2. Company Categorization
8.3. Company Heat Map Analysis
8.4. Company Profiles
- 8.4.1. Novartis AG
  - 8.4.1.1. Participant's Overview
  - 8.4.1.2. Financial Performance
  - 8.4.1.3. Product Benchmarking
  - 8.4.1.4. Recent Developments/ Strategic Initiatives
- 8.4.2. Santen Pharmaceutical Co., Ltd
  - 8.4.2.1. Participant's Overview
  - 8.4.2.2. Financial Performance
  - 8.4.2.3. Product Benchmarking
  - 8.4.2.4. Recent Developments/ Strategic Initiatives
- 8.4.3. AbbVie Inc.
  - 8.4.3.1. Participant's Overview
  - 8.4.3.2. Financial Performance
  - 8.4.3.3. Product Benchmarking
  - 8.4.3.4. Recent Developments/ Strategic Initiatives
- 8.4.4. Kiora Pharmaceuticals, Inc.
  - 8.4.4.1. Participant's Overview
  - 8.4.4.2. Financial Performance
  - 8.4.4.3. Product Benchmarking
  - 8.4.4.4. Recent Developments/ Strategic Initiatives
- 8.4.5. Clearside Biomedical
  - 8.4.5.1. Participant's Overview
  - 8.4.5.2. Financial Performance
  - 8.4.5.3. Product Benchmarking
  - 8.4.5.4. Recent Developments/ Strategic Initiatives
- 8.4.6. Aldeyra Therapeutics, Inc.
  - 8.4.6.1. Participant's Overview
  - 8.4.6.2. Financial Performance
  - 8.4.6.3. Product Benchmarking
  - 8.4.6.4. Recent Developments/ Strategic Initiatives
- 8.4.7. UCB S.A.
  - 8.4.7.1. Participant's Overview
  - 8.4.7.2. Financial Performance
  - 8.4.7.3. Product Benchmarking
  - 8.4.7.4. Recent Developments/ Strategic Initiatives
- 8.4.8. Agilent Technologies, Inc. (Lux Biosciences, Inc.)
  - 8.4.8.1. Participant's Overview
  - 8.4.8.2. Financial Performance
  - 8.4.8.3. Product Benchmarking
  - 8.4.8.4. Recent Developments/ Strategic Initiatives
- 8.4.9. Tarsier Pharma Ltd.
  - 8.4.9.1. Participant's Overview
  - 8.4.9.2. Financial Performance
  - 8.4.9.3. Product Benchmarking
  - 8.4.9.4. Recent Developments/ Strategic Initiatives

전부 포도막염 치료 시장 규모, 점유율, 동향 분석 보고서 : 유형별, 치료별, 유통 채널별, 지역별, 부문별 예측(2024-2030년)

Anterior Uveitis Treatment Market Size, Share & Trends Analysis Report By Type (Infectious Uveitis), By Therapy (Biologics), By Distribution Channel (Hospital, Retail, Online Pharmacies), By Region, And Segment Forecasts, 2024 - 2030

전부 포도막염 치료(Anterior Uveitis Treatment) 시장 성장 및 동향 :

전부 포도막염 치료 시장 보고서· 하이라이트

목차

제1장 조사 방법 및 범위

제2장 주요 요약

제3장 전부 포도막염 치료 시장 변수, 동향, 범위

제4장 전부 포도막염 치료 시장 : 유형별 추정·동향 분석

제5장 전부 포도막염 치료 시장 : 치료별 추정·동향 분석

제6장 전부 포도막염 치료 시장 : 유통 채널별 추정·동향 분석

제7장 전부 포도막염 치료 시장 : 지역별 추정·동향 분석